DNA科学应用 APDN 深 沪
已收盘 10-06 16:00:00 美东时间
5.62
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 5.62
- 总市值 725.82万
- 52周最高 319.95
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 2.13
- 委 比 0.00%
- 总股本 129.15万
- 历史最高 6804000.00
- 量 比 0
- 振 幅 0.00%
- 历史最低 38.025
- 每 手 1
- 风险率 41.95%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Applied DNA Sciences Announces New CEO Appointment
Applied DNA Sciences ( ($APDN) ) has provided an update. On September 29, 2025,...
2025-09-30 04:43
Applied DNA Sciences Secures Up To $58M PIPE To Initiate BNB-Focused Digital Asset Strategy; Intends To Change Ticker To BNBX
Appoints TradFi and DeFi Leaders as Advisers, Including Anthony ScaramucciEnhanced Staking and Yield Strategy Focused on BNB Native Yield Integrating DeFi and Binance Ecosystem ExpertiseOffering Led by Institutional and Crypto-Native Investors including Galaxy, Off The Chain, Silvermine and Gaia Digital Assets
2025-09-30 03:11
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers Enanta Pharma (NASDAQ: ENTA) stock rose 15.6% to $9.13 during Friday's after-market session. The market value of their outstanding shares is at $165.6 million.
2025-09-27 05:06
Applied DNA Sciences Q3 EPS $(33.41) Beats $(37.50) Estimate, Sales $304.393K Miss $1.276M Estimate
Applied DNA Sciences (NASDAQ:APDN) reported quarterly losses of $(33.41) per share which beat the analyst consensus estimate of $(37.50) by 10.91 percent. This is a 3441 percent decrease over earnings of $1.00 per share
2025-08-15 04:51
LineaRxDNA Posts On X "LineaRx is appearing at the 5th Annual mRNA-Based Therapeutics Summit, July 21 - 23 Booth 16. We're thrilled to unveil our latest innovation: the LineaRx IVT Discovery Kit — direct access to our advanced solutions for rapid, high-efficiency mRNA production."
https://x.com/LineaRxDNA/status/1945840253995975135
2025-07-17 21:57
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers ENDRA Life Sciences (NASDAQ:NDRA) stock increased by 50.4% to $5.2 dur...
2025-07-08 05:06
Applied DNA Sciences regains Nasdaq compliance
Applied DNA Sciences (NASDAQ:APDN) announced on Monday that it received a Nasdaq notice informing that the company has regained compliance with Nasdaq's minimum bid price requirement rule of $1.00 per...
2025-07-07 21:19
Applied DNA Sciences to focus solely on synthetic DNA, cuts 27% of staff
Applied DNA Sciences (NASDAQ:APDN) on Monday announced a strategic restructuring and realignment of resources to focus exclusively on its synthetic DNA manufacturing business, LineaRx. As part of act...
2025-06-30 22:31
Applied DNA Chairperson and CEO James A. Hayward resigns
Applied DNA Sciences (NASDAQ:APDN) said on Tuesday that Chairperson and Chief Executive Officer James A. Hayward is retiring from the company and will step down from the board effective June 18, 2025....
2025-06-18 04:15
Applied DNA Sciences Faces Nasdaq Delisting Hearing
Applied DNA Sciences ( ($APDN) ) has issued an announcement. Applied DNA Scienc...
2025-06-07 02:47
